Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000127458 | SCV000171023 | benign | not specified | 2013-12-23 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Color Diagnostics, |
RCV000579510 | SCV000686263 | benign | Hereditary cancer-predisposing syndrome | 2016-06-30 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001164299 | SCV001326414 | uncertain significance | Lynch syndrome 4 | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. |
Invitae | RCV002055749 | SCV002403185 | benign | Hereditary nonpolyposis colorectal neoplasms | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000579510 | SCV002530414 | likely benign | Hereditary cancer-predisposing syndrome | 2021-04-14 | criteria provided, single submitter | curation | |
Ambry Genetics | RCV000579510 | SCV002690948 | likely benign | Hereditary cancer-predisposing syndrome | 2015-07-29 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Center for Genomic Medicine, |
RCV000127458 | SCV004025122 | likely benign | not specified | 2023-08-15 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV003492573 | SCV004239609 | likely benign | Breast and/or ovarian cancer | 2023-05-23 | criteria provided, single submitter | clinical testing | |
Department of Pathology and Laboratory Medicine, |
RCV000127458 | SCV001550955 | benign | not specified | no assertion criteria provided | clinical testing | The PMS2 c.988+11T>C variant was not identified in the literature. The variant was identified in dbSNP (ID: rs139969671) “With Benign allele”, and ClinVar (classified benign by GeneDx and Color). The variant was identified in control databases in 163 (1 homozygous) of 276514 chromosomes at a frequency of 0.0006 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: African in 4 of 24004 chromosomes (freq: 0.0002), Other in 6 of 6450 chromosomes (freq: 0.0009), European Non-Finnish in 19 of 126498 chromosomes (freq: 0.0002), East Asian in 12 of 18864 chromosomes (freq: 0.0006), European Finnish in 120 (1 homozygous) of 25446 chromosomes (freq: 0.005), and South Asian in 2 of 30744 chromosomes (freq: 0.00007) while not observed in the Latino and Ashkenazi Jewish populations. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information this variant meets our laboratory's criteria to be classified as benign. |